Kraft, Colleen S.Sims, MatthewSilverman, MichaelLouie, Thomas J.Feuerstadt, PaulHuang, Edward S.Khanna, SahilBerenson, Charles S.Wang, Elaine E. L.Cohen, Stuart H.Korman, LouisLee, ChristineKelly, Colleen R.Odio, AlbertoCook, Paul P.Lashner, BretRamesh, MayurKumar, PrincyDe, AnanyaMemisoglu, AsliLombardi, David A.Hasson, Brooke R.McGovern, Barbara H.von Moltke, LisaPardi, Darrell S.2024-09-012024-09-012024-08-30https://doi.org/10.1007/s40121-024-01036-8https://hdl.handle.net/1880/119595Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI2024-09-01enThe Author(s)